Skip to main content
. 2024 Oct 3;7:1406365. doi: 10.3389/fdata.2024.1406365

Figure 4.

Figure 4

The XGBoost model's importance matrix plot shows the probability of DAS28 development for each factor in RA pattern diagnosis treated with Patients on Rituximab, Tocilizumab and Abatacept drug. (A) Patients on Rituximab drug. (B) Patients on Tocilizumab drug. (C) Patients on Abatacept drug.